Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-11-17

Clinical Trial Update: Coronary Heart Disease Complicated With Ischemic Mitral Regurgitation in China

View source ↗

Summary

A clinical trial update from China on coronary heart disease with ischemic mitral regurgitation; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Ischemic Mitral Regurgitation, Coronary Heart Disease (CHD) | Status: NOT_YET_RECRUITING